AE Wealth Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-7,786
Closed -$244K – 1276
2023
Q4
$244K Sell
7,786
-388
-5% -$10.5K ﹤0.01% 1809
2023
Q3
$229K Sell
8,174
-809
-9% -$27.8K ﹤0.01% 1729
2023
Q2
$331K Buy
8,983
+996
+12% +$30.4K ﹤0.01% 1567
2023
Q1
$239K Buy
+7,987
New +$263K ﹤0.01% 1653
2022
Q3
– Sell
-6,324
Closed -$203K – 1764
2022
Q2
$203K Sell
6,324
-290
-4% -$10.7K ﹤0.01% 1593
2022
Q1
$208K Buy
6,614
+361
+6% +$11.3K ﹤0.01% 1568
2021
Q4
$210K Buy
+6,253
New +$195K ﹤0.01% 1587

Other funds holding CC

AE Wealth Management's CC Position: Q1 2024 in Review

AE Wealth Management sold out of Chemours (CC) in Q1 2024, closing a stake of 7,786 shares — an estimated $244K sold.

AE Wealth Management first reported a position in CC in Q4 2021 and held it in 7 quarters. The position peaked at $331K in Q2 2023. 444 funds tracked by Wall St. Rank hold CC as of Q1 2024.

  • AE Wealth Management reported no remaining Chemours position as of Q1 2024 after selling out during the quarter.
  • AE Wealth Management sold 7,786 Chemours shares in Q1 2024, an estimated $244K.
  • AE Wealth Management first reported a position in Chemours in Q4 2021 and held it in 7 quarters.
  • AE Wealth Management's Chemours position peaked at $331K in Q2 2023.
  • 444 funds tracked by Wall St. Rank held Chemours as of Q1 2024.

Based on AE Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.